News

Merit Medical Showcases Innovations at CIRSE Annual Congress

Merit Medical Showcases Innovations at CIRSE Annual Congress

Merit Medical Showcases Innovations at CIRSE Annual Congress

Merit Medical Systems, Inc. (NASDAQ: MMSI) is preparing for a notable presence at the upcoming CIRSE Annual Congress, an important gathering for healthcare professionals specializing in cardiovascular and interventional radiology. This event will take place in Lisbon, Portugal, providing an excellent opportunity to share breakthrough research and advances within the medical community.

Highlights from the Presentations

At the congress, clinicians from Merit Medical will unveil crucial updates from two major studies: the WAVE study and the MOTION study. Their presentations are set for September 14, where they will showcase the 6-month clinical outcomes of the WAVE study during a dedicated session. This session, known as FIRST@CIRSE Clinical Trial, will occur from 11:30 to 12:30, attracting medical professionals keen to delve into the latest findings.

Overview of Key Studies

In addition, the session called “Meet the Brains Behind These Landmark Trials,” scheduled for 13:00 to 14:00, will explore the design and methodology of the MOTION study. This presents an exciting chance for attendees to gain insights into the innovative techniques being used to improve patient outcomes in interventional radiology.

Sponsored Symposia at CIRSE

Merit Medical is not just participating in presentations; they are also proud sponsors of two important symposia during the congress. The first symposium will take place on September 15 in Auditorium 2 from 11:30 to 12:30, focusing on the treatment of synovial arterial hypervascularity in the knee, addressing contemporary evidence and management practices. On September 16, in Auditorium 7 from 13:00 to 14:00, the second symposium will concentrate on strategies for ensuring long-term patency for patients undergoing hemodialysis.

Connecting with Healthcare Professionals

Fred Lampropoulos, the Chairman and CEO of Merit Medical, expressed his excitement about participating in the CIRSE Annual Congress. He shared, “We are honored to attend CIRSE, connect with our physician partners, and all interventional radiologists who will attend the conference.” This statement encapsulates the company’s dedication to advancing medical knowledge and building relationships within the healthcare sector.

Accessing Symposium Content

For those who can’t attend in person, it’s been announced that the symposia will be available through a free myCIRSE account. This will allow anyone to participate in live sessions or access them on-demand shortly after their conclusion. This approach ensures that valuable insights are widely shared, particularly among professionals who are unable to travel to the event.

About Merit Medical

Founded in 1987, Merit Medical Systems, Inc. has positioned itself as a leader in creating and distributing innovative medical devices. Their proprietary disposable devices play a crucial role in various interventional, diagnostic, and therapeutic procedures in diverse fields, including cardiology, endoscopy, and oncology. With a dedicated workforce of over 7,100 employees, Merit Medical serves a global clientele, providing high-quality medical products and support.

Frequently Asked Questions

What is the CIRSE Annual Congress?

The CIRSE Annual Congress is a key event in interventional radiology, gathering healthcare professionals from around the world to exchange knowledge and explore advancements in the field.

What studies will Merit Medical present?

Merit Medical will highlight updates from the WAVE study and the MOTION study, focusing on clinical outcomes and trial methodologies, respectively.

How can professionals access the symposia?

The symposia content will be accessible with a free myCIRSE account, allowing both live viewing and on-demand access after the sessions conclude.

What are the main topics of the sponsored symposia?

The first symposium will address the treatment of synovial arterial hypervascularity in the knee, while the second will focus on strategies for ensuring long-term patency for hemodialysis patients.

Who is the CEO of Merit Medical?

Fred Lampropoulos is the Chairman and Chief Executive Officer of Merit Medical Systems, Inc.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 4

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 2

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 0

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 0

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 2

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 3

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 3

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 0

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Sable Resources Secures Financing Through Moxico Partnership

Updated Category News Views 148

Sable Resources Secures Financing Through Moxico Partnership Vancouver, British Columbia – Sable Resources Ltd. (“Sable” or the “Company”) (TSXV: SAE | OTCQB: SBLRF) recently announced the successful closing of a non-brokered private placement, raising C$1.75 million in funding. This financing comes from an agreement with Moxico Resources plc, wherein Sable...

Continue Reading
Coherus BioSciences Unveils Robust Q1 2025 Financials

Updated Category News Views 399

Coherus BioSciences Reports Q1 Financial Results Coherus BioSciences, Inc. (Nasdaq: CHRS) has recently released its financial results for the first quarter of 2025. This update also highlights significant developments within the company, especially in the field of oncology. Strategic Focus on Innovative Oncology As part of its strategic transformation towards becoming an...

Continue Reading
Understanding the Rise in Comfort Systems USA's Short Interest

Updated Category News Views 134

Understanding Comfort Systems USA's Short Interest The short interest of Comfort Systems USA (NYSE: FIX) has seen a notable rise, increasing by 40.65% since the last report. This reflects growing concerns or speculation surrounding the company's stock performance. Currently, approximately 536 thousand shares are sold short, which constitutes 2.18% of the total shares...

Continue Reading
Kinetics Noise Control Elevates Logan Herkomer to HVAC Director

Updated Category News Views 129

Kinetics Noise Control Elevates Logan Herkomer to HVAC Director Kinetics Noise Control Inc. (Kinetics), a leader in the noise control products sector, has announced a significant leadership change. Logan Herkomer has been promoted to HVAC Sales Director, a role in which he will oversee the company's national sales strategies for HVAC products. This change is effective...

Continue Reading
Shanghai Electric Showcases Sustainable Innovations at Intersolar

Updated Category News Views 212

Shanghai Electric Showcases Sustainable Innovations at Intersolar Shanghai Electric has made a significant statement at this year's Intersolar Europe, a premier event dedicated to advancing the solar industry. The company's dedication to fostering innovative technologies is evident in its latest offerings in photovoltaic and hydrogen energy, along with advanced energy...

Continue Reading